RDRichard A. Decreau

Richard A. Decreau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Richard A. Decreau has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Picket fence phthalocyanine bearing a proximal tail as a heme protein mimic

    by Sébastien Saou, Vivian Lioret, Paul Fleurat-Lessard, Marie-José Penouilh, Yann Bernhard, Richard A. Decréau

    A myoglobin active site model was synthesized from an iron phthalocyanine platform upon covalent attachment of a coordinating proximal tail and distal picket fence.

  • Liposome: a tool to raise the Cherenkov radiation yield and to restore fluorophore properties in aqueous media

    by Sébastien Saou, Mathieu Moreau, Vivian Lioret, Anne Berrou, Marta Hernandez-Garcia, Richard A. Decréau

    Liposomes used for the study were prepared and carefully characterized multiple times until all batches indicated the same characterization data (DOPC/cholesterol derivative (1 : 1.15 mol%), 14 mg(DOPC) mL−1, dDLS = 130 nm, 2 × 1011 liposome per nm3 of prepared batch, polydispersity index PDI = 0.1). The study shows that such a liposome suspension raises the yield in Cherenkov Radiation (CR) by 1.6-fold when in presence of [68Ga]-GaCl3, an efficient CR emitter (beta particle energy Eβ + = 1800 KeV). Also, liposomes were found to prevent aggregation of a water-soluble phthalocyanine-pyranine PcPy4 dyad upon encapsulation, leading to its spectacular fluorescence restoration. Altogether, upon efficient 68Ga-radiolabelling of NODAGA-chelate immobilized at the liposome surface (99% radiolabelling yield, radio-TLC showed) encapsulating PcPy4 dyad (Caverage = 97 μM, Clumen = 300 μM), subsequent Cherenkov Radiation Energy Transfer (CRET) at the dyad antenna occurred. Internal energy transfers and fluorescence emission from the emitter dyad led to a 2.6-fold raise in radiance measured in the near-infrared (NIR) window (i.e. ca. 400 nm pseudo-Stokes shift). A similar raise in radiance was measured in the green window when encapsulation was achieved with eosin at the same rate. Liposome were found to be stable in PBS over 7 days regardless of the encapsulated fluorophore (no raise in dDLS diameter, no release of encapsulated dyes measured after Sephadex and FPLC repurification sequence), with some decay over 22 hours in a PBS/fetal calf serum mixture (1 : 1 vol.).

  • Cherenkov radiation energy transfer from [18F]-fluorodeoxyglucose to subphthalocyanine fluorophores

    by Vivian Lioret, Richard A. Decréau

    Cherenkov radiation (CR) is an optical light that is emitted during the decay of beta-particle-emitting radionuclides, such as 18 F, which is present in [ 18 F]-fluorodeoxyglucose, a well-known tracer used in positron emission tomography. The CR emission occurs from relaxation of molecules of the dielectric medium surrounding the emitted beta-particle. The Cherenkov radiation energy transfer (CRET) to a CR acceptor, such as subphthalocyanine, was analyzed. Subphthalocyanine is a unique concave-shaped 14 π -electron fluorophore with optical properties. The relevance of such a CR emitter/acceptor couple to performing CRET is discussed.


  • Cherenkov Radiation induced photodynamic therapy - repurposing older photosensitizers, and radionuclides

    by Vivian Lioret, Pierre-Simon Bellaye, Yann Bernhard, Mathieu Moreau, Mélanie Guillemin, Camille Drouet, Bertrand Collin, Richard A. Decréau


  • Open Access

    Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia

    by Alexandre M. M. Dias, Alan Courteau, Pierre-Simon Bellaye, Evelyne Kohli, Alexandra Oudot, Pierre-Emmanuel Doulain, Camille Petitot, Paul-Michael Walker, Richard Decréau, Bertrand Collin

    Cancer immunotherapy has tremendous promise, but it has yet to be clinically applied in a wider variety of tumor situations. Many therapeutic combinations are envisaged to improve their effectiveness. In this way, strategies capable of inducing immunogenic cell death (e.g., doxorubicin, radiotherapy, hyperthermia) and the reprogramming of the immunosuppressive tumor microenvironment (TME) (e.g., M2-to-M1-like macrophages repolarization of tumor-associated macrophages (TAMs)) are particularly appealing to enhance the efficacy of approved immunotherapies (e.g., immune checkpoint inhibitors, ICIs). Due to their modular construction and versatility, iron oxide-based nanomedicines such as superparamagnetic iron oxide nanoparticles (SPIONs) can combine these different approaches in a single agent. SPIONs have already shown their safety and biocompatibility and possess both drug-delivery (e.g., chemotherapy, ICIs) and magnetic capabilities (e.g., magnetic hyperthermia (MHT), magnetic resonance imaging). In this review, we will discuss the multiple applications of SPIONs in cancer immunotherapy, focusing on their theranostic properties to target TAMs and to generate MHT. The first section of this review will briefly describe immune targets for NPs. The following sections will deal with the overall properties of SPIONs (including MHT). The last section is dedicated to the SPION-induced immune response through its effects on TAMs and MHT.


  • Water soluble octa-imidazolium zinc phthalocyanine for nucleus/nucleolus cell fluorescence microscopy and photodynamic therapy

    by Vivian Lioret, Sébastien Saou, Anne Berrou, Liana Lernerman, Christine Arnould, Richard A. Decréau

    A poly-cationic theranostic macrocycle was developed to perform confocal microscopy imaging and photodynamic therapy studies on a model of melanoma cancer, one of the most aggressive cancer. Hence, an octa-imidazolium zinc phthalocyanine was conveniently synthesized in large amount in three steps in a 44% overall yield: upon double nucleophilic aromatic substitution, cyclo-tetramerization and quaternization reactions. Such an octa-cationic molecule was readily soluble in physiological media, reaching concentrations beyond 1 mM. It showed fluorescence properties in aqueous medium (ΦF = 0.31) with no noticeable aggregation, spectroscopy studies showed. In vitro confocal fluorescence microscopy studies carried out on murine melanoma model (B16F10 cells) showed that the fluorophore was mainly located in the cell nucleolus, an organelle of interest for the treatment of cancer. The anticancer photodynamic potential of the octa-cationic photosensitizer could be measured (IC50 = 5.4 µM) using the MTS viability assay. Both fluorescence microscopy studies and photodynamic studies demonstrate the octa-cationic molecule is theranostic and could be further developed for future photodynamic diagnosis (PDD) and photodynamic inactivation of micro-organisms (PDI). Graphical abstract


  • Dual Cherenkov Radiation-Induced Near-Infrared Luminescence Imaging and Photodynamic Therapy toward Tumor Resection

    by Vivian Lioret, Pierre-Simon Bellaye, Christine Arnould, Bertrand Collin, Richard A. Decréau

    Cherenkov Radiation (CR), the blue light seen in nuclear reactors is emitted by some radiopharmaceuticals. This study showed that 1) a portion of CR could be transferred in the region of the optical spectrum where biological tissues are most transparent: as a result, upon radiance amplification in the NIR window, the detection of light could occur twice deeper in tissues than during classical Cherenkov Luminescence Imaging (CLI). 2) Cherenkov-Photodynamic Therapy (CR-PDT) on cells could be achieved under conditions mimicking unlimited depth using CR embarked light source, which is unlike standard Photodynamic Therapy (PDT) where light penetration depth is limited in biological tissues. Both results are of utmost importance for simultaneous applications in tumor resection and post-resection treatment of remaining un-resected margins, thanks to a molecular construct designed to raise its light collection efficiency (i.e. CR Energy Transfer (CRET)) by conjugation with multiple CR-absorbing (water-soluble) antenna followed by intramolecular-FRET/TBET energy transfers.


  • Resonant inelastic X-ray scattering determination of the electronic structure of oxyhemoglobin and its model complex

    by James J. Yan, Thomas Kroll, Michael L. Baker, Samuel A. Wilson, Richard Decréau, Marcus Lundberg, Dimosthenis Sokaras, Pieter Glatzel, Britt Hedman, Keith O. Hodgson, et al.

    Hemoglobin and myoglobin are oxygen-binding proteins with S = 0 heme {FeO2}8 active sites. The electronic structure of these sites has been the subject of much debate. This study utilizes Fe K-edge X-ray absorption spectroscopy (XAS) and 1s2p resonant inelastic X-ray scattering (RIXS) to study oxyhemoglobin and a related heme {FeO2}8 model compound, [(pfp)Fe(1-MeIm)(O2)] (pfp = meso-tetra(α,α,α,α-o-pivalamido-phenyl)porphyrin, or TpivPP, 1-MeIm = 1-methylimidazole) (pfpO2), which was previously analyzed using L-edge XAS. The K-edge XAS and RIXS data of pfpO2 and oxyhemoglobin are compared with the data for low-spin FeII and FeIII [Fe(tpp)(Im)2]0/+ (tpp = tetra-phenyl porphyrin) compounds, which serve as heme references. The X-ray data show that pfpO2 is similar to FeII, while oxyhemoglobin is qualitatively similar to FeIII, but with significant quantitative differences. Density-functional theory (DFT) calculations show that the difference between pfpO2 and oxyhemoglobin is due to a distal histidine H bond to O2 and the less hydrophobic environment in the protein, which lead to more backbonding into the O2. A valence bond configuration interaction multiplet model is used to analyze the RIXS data and show that pfpO2 is dominantly FeII with 6–8% FeIII character, while oxyhemoglobin has a very mixed wave function that has 50–77% FeIII character and a partially polarized Fe–O2 π-bond. Significance The electronic structure of the heme oxy-iron center in oxyhemoglobin and oxymyoglobin has been the subject of debate for decades. Various experimental and computational methods have been used to study this system, leading to conflicting conclusions. This study uses X-ray spectroscopy to directly probe the iron center in the highly delocalized oxyhemoglobin and its model compound to define the electronic structure and understand the differences between the protein and the model. This study settles a longstanding debate in bioinorganic chemistry and provides insight into heme iron–oxygen binding, the key first step in many biocatalytic processes.


  • Open Access

    Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo

    by Emiko Desvaux, Alan Courteau, Pierre-Simon Bellaye, Mélanie Guillemin, Camille Drouet, Paul Walker, Bertrand Collin, Richard A. Decréau

    Molecular imaging techniques visualise biomarkers for both drug development and personalised medicine. In this field, Cherenkov luminescence imaging (CLI) seems to be very attractive by allowing imaging with clinical PET radiotracers with high-throughput capabilities. In this context, we developed a fast CLI method to detect tumour hypoxia with 18F-fluoromisonidazole (FMISO) for drug development purposes. Colon cancer model was induced in mice by subcutaneous injection of 1 × 106 CT-26 cells. FMISO was injected, and simultaneous PET-blood oxygen level dependent (BOLD)-MRI followed by CLI were performed along with immunohistochemistry staining with pimonidazole. There was a significant correlation between FMISO PET and CLI tumour uptakes, consistent with the BOLD-MRI mapping. Tumour-to-background ratio was significantly higher for CLI compared with PET and MRI. Immunohistochemistry confirmed tumour hypoxia. The imaging workflow with CLI was about eight times faster than the PET-MRI procedure. CLI is a fast and relevant tool to assess tumour hypoxia. This approach could be particularly interesting for hypoxia-targeting drug development.